Literature DB >> 30376373

Modulation of IGF1R Signaling Pathway by GIGYF1 in High Glucose-Induced SHSY-5Y Cells.

Ting Zhou1, Yuefei Ma1, Juan Tang1, Fengqi Guo1, Mingxia Dong1, Qianping Wei1.   

Abstract

Grb10 (growth factor receptor-bound protein 10)-interacting GYF protein 1 (GIGYF1) can modulate insulin-like growth factor 1 receptor (IGF1R) signaling pathway, which plays an important role in regulating diabetes-associated cognitive impairment, by linking to Grb10 adapter. However, it remains unclear whether endogenous GIGYF1 expression is associated with the development of diabetes-related cognitive impairment. In this study, we measured the expression level of GIGYF1, Grb10, phosphorylated IGF1R/IGF1R, phosphorylated AKT serine/threonine protein kinase/protein kinase B (AKT)/AKT, and phosphorylated extracellular signal-regulated kinase (ERK)/ERK in human neuroblastoma SHSY-5Y cells. Meanwhile, we detected cell apoptosis, proliferation, and migration. Our results showed that the percentage of apoptotic cells increased along with the increasing concentrations of glucose (0-200 mM). The expression of GIGYF1 had a significant increase in the presence of 25 mM concentration of glucose in SHSY-5Y cells. In addition, high glucose augmented the expression of IGF1R and Grb10, but decreased the expression of p-IGF1R, p-AKT, and p-ERK. However, GIGYF1 knockdown reversed the decline in the expression of p-IGF1R, p-AKT, and p-ERK. In addition, knocking down GIGYF1 promoted the proliferation and migration of SHSY-5Y cells, but inhibited the apoptosis in SHSY-5Y cells. These results demonstrate that the expression of GIGYF1 can regulate IGF1R signaling pathway in high glucose-induced SHSY-5Y cells.

Entities:  

Keywords:  AKT; ERK; GIGYF1; Grb10; IGF1R; SHSY-5Y cells

Year:  2018        PMID: 30376373     DOI: 10.1089/dna.2018.4336

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  1 in total

1.  GIGYF1 disruption associates with autism and impaired IGF-1R signaling.

Authors:  Guodong Chen; Bin Yu; Senwei Tan; Jieqiong Tan; Xiangbin Jia; Qiumeng Zhang; Xiaolei Zhang; Qian Jiang; Yue Hua; Yaoling Han; Shengjie Luo; Kendra Hoekzema; Raphael A Bernier; Rachel K Earl; Evangeline C Kurtz-Nelson; Michaela J Idleburg; Suneeta Madan-Khetarpal; Rebecca Clark; Jessica Sebastian; Alberto Fernandez-Jaen; Sara Alvarez; Staci D King; Luiza Lp Ramos; Mara Lucia Sf Santos; Donna M Martin; Dan Brooks; Joseph D Symonds; Ioana Cutcutache; Qian Pan; Zhengmao Hu; Ling Yuan; Evan E Eichler; Kun Xia; Hui Guo
Journal:  J Clin Invest       Date:  2022-10-03       Impact factor: 19.456

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.